A drug utilisation study to assess the effectiveness of risk minimisation measures and describe the prescribing practices of Doreta SR and tramadol/paracetamol combinations in Europe (DUS Doreta SR and tramadol/paracetamol combination)

06/07/2022
30/01/2025
EU PAS number:
EUPAS47961
Study
Finalised
Documents
Study protocol
Initial protocol
English (2.5 MB - PDF) View document
Updated protocol
English (755.4 KB - PDF) View document
Study results
Study report
Study report
English (1.39 MB - PDF) View document
Other information